Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Dime Community Bancshares, a New York-based bank holding company, announced the appointment of Meyer Eichler as Executive Vice President and Managing Executive Director. Eichler will focus on expanding Dime's presence within the Orthodox Jewish community in New York and New Jersey, targeting key sectors such as healthcare, real estate, retail, whol…
Medicus Pharma announced new Phase 1 clinical data for Teverelix, its investigational long-acting GnRH antagonist, demonstrating predictable estradiol suppression, favorable pharmacokinetics for infrequent dosing, and good safety profile. The findings support advancing Teverelix development for hormone-driven conditions including endometriosis and …
Bitdeer Technologies Group announced significant operational growth in March 2026, including a 480% year-over-year increase in Bitcoin production to 661 BTC and a 105% month-over-month rise in AI cloud annual recurring revenue to approximately $43 million. The company is expanding its AI and Bitcoin mining infrastructure, advancing new colocation d…
TG Therapeutics announced the completion of enrollment for its Phase 3 trial testing subcutaneous delivery of BRIUMVI, an anti-CD20 monoclonal antibody for relapsing multiple sclerosis (RMS). The study compares two dosing regimens administered subcutaneously to the existing intravenous formulation, aiming to demonstrate non-inferiority in drug expo…
Prelude Therapeutics announced the appointment of Dr. Charles Morris as Chief Medical Officer effective April 20, 2026. Dr. Morris brings over 30 years of oncology drug development experience and will support Prelude's advancing clinical programs targeting myeloproliferative neoplasms and ER+ breast cancer, with clinical development expected to beg…
Ridgepost Capital, a leading provider in private markets solutions, announced it will release its Q1 2026 financial results on May 7, 2026, prior to the U.S. market open. The company will also host an earnings conference call the same day to discuss results and outlook. Ridgepost Capital manages over $43 billion in assets, focusing on Private Equit…
Arbutus Biopharma announced that the U.S. FDA has granted Fast Track designation for their RNAi therapeutic imdusiran targeting chronic hepatitis B. This designation may accelerate the drug’s review and development, offering potential benefits such as earlier FDA interactions and expedited approval pathways. Clinical trials showed promising results…
Plus Therapeutics, a clinical-stage healthcare company specializing in precision diagnostics and radiopharmaceuticals for CNS cancers, has appointed Randy H. Goodman, PhD, MHA, as Vice President of Value Strategy & HEOR. Goodman brings over 20 years of experience in health economics, market access, and payer engagement, expected to fortify Plus The…
Alterity Therapeutics announced a virtual event featuring key opinion leaders to discuss insights on their lead drug candidate ATH434 for Multiple System Atrophy (MSA). The company will review Phase 2 clinical trial results demonstrating clinical efficacy and provide a high-level overview of the planned Phase 3 pivotal trial. The event aims to info…
Monarch Casino & Resort, Inc. announced that its slot machine change donation program at Atlantis Casino Resort Spa in Reno and Monarch Casino Resort Spa Black Hawk has exceeded $1 million in contributions to various charities. Powered by IGT technology, the program allows guests to easily donate their remaining slot machine change to nonprofit org…
Tilray Brands, Inc. announced a series of strategic initiatives to accelerate its global growth across healthcare, cannabis, and beverage sectors. Key actions include acquiring the UK-based Lyphe Group to enhance its medical cannabis ecosystem, strengthening its recently acquired BrewDog beverage platform, and positioning itself to capitalize on po…
Traws Pharma announced a private placement financing expected to raise approximately $10 million in gross proceeds initially, with potential additional proceeds up to $50 million through milestone-based and three-year warrants. The financing will support the completion of a human challenge trial for its influenza treatment tivoxavir marboxil in the…
BillionToOne, a molecular diagnostics company traded on NASDAQ under the ticker BLLN, will release its financial results for the first quarter of 2026 on May 6, 2026, followed by a conference call to discuss the results. The company specializes in advanced DNA molecular counting technology aimed at creating accessible, powerful diagnostic tests.
Union Bankshares, Inc. announced a net income increase to $3.0 million ($0.65 per share) for Q1 2026, driven by growth in net interest income and strong asset management. The bank's total assets rose by 6.6% year-over-year to $1.63 billion, with strategic investment securities growth. The company declared a $0.36 per share quarterly dividend, refle…
60 Degrees Pharmaceuticals announced that its FDA-approved malaria prevention drug ARAKODA (tafenoquine) is now available for purchase through the Runway Health telehealth platform, enabling U.S. travelers to conveniently obtain prescriptions and receive medication delivered prior to traveling to malaria-endemic regions. The once-weekly dosing regi…
Capital Clean Energy Carriers Corp. has agreed to sell a 49% stake in its LNG carrier Amore Mio I to an affiliate of BGN Group via a new joint venture. The joint venture secured a 10-year time charter agreement with BGN INT DMCC, expected to generate revenues up to $485.6 million, enhancing the company's charter portfolio, financial flexibility, an…
Mesoblast Limited has secured an exclusive worldwide license to innovative chimeric antigen receptor (CAR) technology developed at Mayo Clinic to genetically engineer its mesenchymal stromal cell (MSC) products. The integration aims to significantly improve targeted homing, immunomodulation, and tissue regeneration capabilities of Mesoblast’s FDA-a…
The Chefs' Warehouse, Inc., a specialty food products distributor, announced it will release its first quarter 2026 financial results on April 29, 2026, before market open. The company will also hold a live conference call to discuss the results the same morning.
CCC Intelligent Solutions has integrated consumer financing via Sunbit into its CCC ONE® platform, enabling collision repair shops to offer customers flexible, fast, and transparent financing options with high approval rates and no hidden fees. This feature aims to help shops convert more repair estimates into approved work by removing cost-related…
Toll Brothers, a leading US luxury home builder, announced the last homes available in its Santa Rosa Valley Estates gated community in California. The community features spacious, high-end homes with modern designs, large lot sizes, and optional multigenerational suites, with prices starting from $3.18 million. This marks the final opportunity for…
One Stop Systems, Inc. reported record quarterly earnings per share and gross margins for 2025, with revenue growth of 31.2% and a strengthened strategic focus on rugged Enterprise Class compute solutions for AI and sensor processing at the edge. The company highlighted expanding defense contracts, including the P-8 Poseidon program, and growth in …
Sprott Inc. announced the launch of the Sprott Rare Earths Ex-China ETF (Nasdaq: REXC), the only ETF offering focused exposure to rare earth companies operating outside of China. This ETF addresses the strategic importance of diversifying rare earth element supply chains critical for advanced technology sectors like defense, AI, EVs, and semiconduc…
Picard Medical, trading on NYSE American as PMI, highlighted the successful use of its SynCardia Total Artificial Heart (STAH) as a life-saving bridge to transplant at Texas Children's Hospital for a 21-year-old patient undergoing a complex heart re-transplant. This case underscores the critical role and flexibility of the STAH in managing advanced…
TeraWulf Inc. priced an upsized public common stock offering of 47.4 million shares at $19.00 per share, raising gross proceeds of about $900 million. The offering aims to fund construction of a new data center campus in Kentucky, repay bridge credit facility obligations, and support future site acquisitions and corporate purposes. The transaction …
Byrna Technologies Inc., a Nasdaq-listed personal defense technology company, has promoted Matthew Campagni to Chief Strategy Officer. Campagni brings over 25 years of leadership in strategy, operations, and finance within public safety and technology sectors. His appointment aims to strengthen Byrna's strategic planning and execution as the compan…
